Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 06  •  04:00PM ET
1.88
Dollar change
+0.19
Percentage change
11.24
%
Feb 02, 12:01 PMAnticipation for Emperor artificial heart webinar fueled the 24.86% gain.
IndexRUT P/E- EPS (ttm)-0.51 Insider Own64.53% Shs Outstand73.70M Perf Week7.43%
Market Cap138.56M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float26.14M Perf Month-1.57%
Enterprise Value136.37M PEG- EPS next Q- Inst Own0.84% Short Float2.61% Perf Quarter-43.03%
Income-33.80M P/S29.05 EPS this Y- Inst Trans0.61% Short Ratio0.70 Perf Half Y-
Sales4.77M P/B17.39 EPS next Y- ROA-245.79% Short Interest0.68M Perf YTD7.43%
Book/sh0.11 P/C49.31 EPS next 5Y- ROE- 52W High13.68 -86.26% Perf Year-
Cash/sh0.04 P/FCF- EPS past 3/5Y-36.87% - ROIC-414.78% 52W Low1.58 18.99% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y3.32% - Gross Margin-10.83% Volatility14.38% 9.38% Perf 5Y-
Dividend TTM- EV/Sales28.59 EPS Y/Y TTM-77.65% Oper. Margin-289.61% ATR (14)0.20 Perf 10Y-
Dividend Ex-Date- Quick Ratio0.94 Sales Y/Y TTM8.97% Profit Margin-707.92% RSI (14)48.81 Recom-
Dividend Gr. 3/5Y- - Current Ratio2.16 EPS Q/Q-101.16% SMA204.79% Beta- Target Price-
Payout- Debt/Eq0.08 Sales Q/Q34.73% SMA50-8.30% Rel Volume0.07 Prev Close1.69
Employees75 LT Debt/Eq0.02 Earnings- SMA200-58.34% Avg Volume975.04K Price1.88
IPOAug 29, 2025 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume71,509 Change11.24%
Feb-05-26 04:05AM
Jan-29-26 04:05PM
Jan-13-26 09:00AM
Jan-12-26 08:30AM
Jan-07-26 08:00AM
08:00AM Loading…
Jan-06-26 08:00AM
Dec-30-25 08:00AM
Dec-26-25 06:25AM
Dec-24-25 09:36AM
Dec-18-25 08:55AM
08:30AM
Dec-09-25 04:05PM
Dec-03-25 04:05PM
Nov-26-25 07:00AM
Nov-19-25 04:05PM
07:00AM Loading…
Nov-14-25 07:00AM
Nov-12-25 08:00AM
Nov-03-25 08:00AM
Oct-24-25 03:07PM
Oct-08-25 10:51AM
Sep-22-25 08:00AM
Sep-15-25 08:00AM
Sep-10-25 08:00AM
Sep-09-25 04:05PM
Sep-08-25 07:00AM
Sep-02-25 04:05PM
Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. It develops the first fully implantable SynCardia TAH as an alternative to heart transplantation for patients with biventricular heart failure in the U.S. and around the world. The company is headquartered in Tucson, AZ.